Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LA6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,903
Award facts
- Contract value 100% obligated
- $36,903.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,903.35 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of Mounjaro 10 mg/0.5 ml pens in 0.5 ml quantities. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by January 14, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (UEI: NWEGNLYTBDW4), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
Mounjaro is a diabetes medication widely used in military and federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contracts supplying medications, vaccines, and medical supplies across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other government medical institutions. The firm's demonstrated capability to meet federal procurement requirements through open competition and its significant pharmaceutical supply agreements with DLA position it as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9LA6?
SPE2DR26F9LA6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9LA6 worth?
The government has obligated $36,903 on SPE2DR26F9LA6.
Is contract SPE2DR26F9LA6 an order under another contract?
Yes. SPE2DR26F9LA6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LA6 competed?
The extent of competition for SPE2DR26F9LA6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award